Dr. Axe Wire · Study decoded · health

Mindfulness Therapy Brings Small Quality-of-Life Gain in Schizophrenia

A new analysis of nine trials and 567 adults finds mindfulness-based therapy gave a small quality-of-life gain over control groups, though certainty of the evidence is low.

By Dr. Axe Editorial Team · October 29, 2026 · 1 source · Understand

Photo: Pexels

A meta-analysis published October 21, 2026 in the journal Mindfulness found that mindfulness and acceptance-based therapies produced a small improvement in quality of life for adults with schizophrenia spectrum disorders compared with control conditions.

567adults, 9 trials

0.26effect size

Researchers searched six databases through March 2026 and identified ten eligible studies, with nine randomized controlled trials totaling 567 adults with schizophrenia spectrum disorders contributing to the main analysis. All compared mindfulness- or acceptance-based interventions, such as mindfulness-based group therapy or acceptance and commitment therapy, against control conditions, with quality of life measured using validated questionnaires.

The pooled result showed a small improvement in quality of life among people who received the therapies, corresponding to a standardized effect size of 0.26, with a range of 0.06 to 0.46. That result held up under a more conservative statistical method. Whether a trial included a follow-up assessment was the only factor that produced a meaningfully different result between subgroups of studies.

Many people with schizophrenia spectrum disorders continue to struggle with day-to-day life satisfaction even after their psychiatric symptoms improve. Mindfulness and acceptance-based approaches train people to notice difficult thoughts and sensations without being pulled into them, which the authors note is something medication addresses poorly.

Quality-of-Life Effect Size

Mindfulness, 2026, Özdemir & Boğahan

The authors rated the overall certainty of evidence as low, and the range of plausible effects in a future similar trial crossed zero, meaning some future trials could find no benefit at all. The review combined different types of mindfulness and acceptance therapies and control conditions, so it is not yet clear which specific approach works best.

Dr. Axe’s Take

A small but consistent gain across nine trials and 567 people is worth acting on, because almost nothing in standard psychiatric care targets quality of life directly. I see mindfulness as a regular part of care alongside medication, so don't stop a prescription on your own. If you're supporting a loved one with schizophrenia, I'd look for a local mindfulness-based or acceptance and commitment therapy group this week and build around it with steady sleep, daily movement and real social connection.

— Dr. Axe

Take the Cellular Health Quiz →

Study summary

Who: 567 adults with schizophrenia spectrum disorders in nine randomized trials; ten studies met inclusion criteria.
Design: Meta-analysis of RCTs comparing mindfulness/acceptance therapies with control conditions, PRISMA 2020, searched through March 2026.
Dose: Varied by trial: mindfulness-based group therapy or acceptance and commitment therapy, vs. control conditions.
Primary result: Small QoL improvement, effect size 0.26 (95% CI 0.06-0.46), robust to a stricter statistical method.
Secondary: Follow-up assessment availability was the only subgroup factor with a meaningful difference; future-trial range crossed zero.
Funding / conflicts: No specific grant funded this research. The authors declare no competing interests.
Date: Oct 21, 2026